At 7.9x earnings with a 0.2 forward PEG, the market is pricing BCRX like a no-growth cyclical despite clear signals of operating leverage and capital efficiency. A Forward P/E of 11.9 alongside an Altman Z-Score of 2.6 suggests a company in the gray zone—neither distressed nor fortress-strong—but far from a balance-sheet crisis. The combination of a $2,397M market cap, 12.60% ROE, and an elite 107.20% ROIC against a depressed multiple creates a visible valuation disconnect. This is not a balance-sheet implosion story; it’s a profitability volatility story, and the market appears to be discounting operational instability more heavily than the capital returns justify.